Приказ основних података о документу

dc.creatorBubić Pajić, Nataša
dc.creatorNikolić, Ines
dc.creatorDobričić, Vladimir
dc.creatorSavić, Snežana
dc.date.accessioned2024-01-17T11:15:40Z
dc.date.available2024-01-17T11:15:40Z
dc.date.issued2019
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/5456
dc.description.abstractAdapalene (ADA) belongs to the group of retinoids, synthetic analogs of retinol, and it is used as a first line therapy of mild to moderate acne, with a few exceptions (1). However, dermal availability of ADA is limited due to its poor aqueous solubility. In order to enhance the drug penetration into target areas (i.e. hair follicles and epidermis), several strategies, such as liposomes, microemulsions (MEs), solid lipid microparticles, nanostructured lipid carriers etc., were proposed recently. MEs have been reported as a promising tool for topical drug delivery because they combine several advantages over conventional formulations, including ease of manufacture, high solubilization potential for poorly soluble drugs, reduced side effects, long-term stability and improved drug penetration through/into the skin (2).sr
dc.language.isoensr
dc.relationinfo:eu-repo/grantAgreement/MESTD/Technological Development (TD or TR)/34031/RS//sr
dc.rightsrestrictedAccesssr
dc.source3rd European Conference on Pharmaceutics, 25 to 26 March, 2019, Bologna, Italy, Abstract booksr
dc.titleBiopharmaceutical properties of adapalene loaded biocompatible microemulsionssr
dc.typeconferenceObjectsr
dc.rights.licenseARRsr
dc.identifier.rcubhttps://hdl.handle.net/21.15107/rcub_farfar_5456
dc.type.versionpublishedVersionsr


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу